Quantbot Technologies LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 186 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.

Quarter-by-quarter ownership
Quantbot Technologies LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$94,923
+578.0%
1,421
+1444.6%
0.01%
+600.0%
Q4 2021$14,000
+250.0%
92
+187.5%
0.00%
Q3 2021$4,000
-94.6%
32
-95.9%
0.00%
-100.0%
Q3 2020$74,000
+428.6%
780
+486.5%
0.01%
+300.0%
Q2 2020$14,000133
+1377.8%
0.00%
Q1 2020$0
-100.0%
9
-98.7%
0.00%
-100.0%
Q4 2019$73,000
-49.3%
705
-51.3%
0.01%
-50.0%
Q3 2019$144,000
+1100.0%
1,447
+1347.0%
0.01%
+1300.0%
Q1 2019$12,000
-95.8%
100
-95.3%
0.00%
-96.4%
Q4 2018$289,000
+556.8%
2,137
+410.0%
0.03%
+460.0%
Q1 2017$44,000
-90.6%
419
-90.9%
0.01%
-90.4%
Q3 2016$467,000
+2235.0%
4,581
+2190.5%
0.05%
+1200.0%
Q2 2015$20,000
-60.0%
200
-78.9%
0.00%
-75.0%
Q4 2014$50,000
-31.5%
949
-13.7%
0.02%
-5.9%
Q1 2014$73,000
+1360.0%
1,100
+1000.0%
0.02%
+750.0%
Q4 2013$5,0001000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders